OVID: Ovid Therapeutics Inc. Forvard P/E multiplikatori

Ovid Therapeutics (OVID) kompaniyasining rasmiy ramzlari

Kamyob dori vositasi maqomi monopoliyani yaratib, ushbu tor doiradagi bozorni ulkan kapitalga ega bo'lmagan ishtirokchilardan himoya qiladi. Ovid Therapeutics Inc. (OVID) kompaniyasining forward P/E koeffitsiyenti ushbu to'siqni vizuallashtiradi, bunda 0.00 qiymati bozor kutganlarining joriy darajasini tavsiflaydi. Epilepsiya dori vositalari uchun patentlar va texnologik gigantlar bilan hamkorlik poydevorni mustahkamlaydi, sertifikatlangan laboratoriyalarning barqaror ishlashi esa klinik sinovlarning uzluksiz o'tkazilishini kafolatlaydi.

OVID - Ovid Therapeutics Narxning kelajakdagi foydaga nisbati 04.07.2022 - 17.11.2026 oraligʻida

Ovid Therapeutics Inc. (OVID) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Fundamental baholash:Ovid Therapeutics
Ovid Rx tovar namunasi

Nevrologik loyihalar portfelining shaffofligi va doktor Levining litsenziyalash kelishuvlari bo'yicha tajribasi GURU.Markets platformasidagi Ovid Therapeutics Inc. (OVID) kompaniyasining kelgusi 12 oylik (NTM) P/E ko'rsatkichi bozor kutganlarini aniq aks ettiruvchi barometrga aylantiradi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini prognoz qilingan foyda bilan solishtiradi, bu esa investorlarga aksiyalar narxining kelgusi pul oqimlari nisbatidagi adolatli ekanligini baholash va global kapital oqimlaridagi anomaliyalarni aniqlash imkonini beradi.

Ovid Therapeutics Inc. (OVID) raqobatchilari

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Acumen Pharmaceuticals Inc. - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CervoMed Inc|ATHE: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Clene Nanomedicine|Kelajakdagi narxning foydaga nisbati PepGen Corp|Jupiter Neurosciences (JUNS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Relmada Therapeutics, Inc. (RLMD)|ANVS - Prognoz qilingan narx-foyda nisbati|gracetx.com - Prognoz qilingan narxning foydaga nisbati|AIFF: Narxning kelajakdagi foydaga nisbati|Klotho Neurosciences - Forvard P/E multiplikatori|NRSN (NeuroSense Therapeutics Ltd.) - Narxning kelajakdagi foydaga nisbati|Reviva Pharmaceuticals (RVPH) - Kelajakdagi narxning foydaga nisbati|MTVA (MetaVia Inc.) - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati NeurAxis, Inc|Kelajakdagi narxning foydaga nisbati HSDT|Forvard P/E multiplikatori PASG|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neuphoria Therapeutics, Inc.|minervaneurosciences.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Athira ATHA|Addex Therapeutics - Forvard P/E multiplikatori|ALZN - Forvard P/E multiplikatori|Cyclerion (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic (PTIX) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Pasithea|Narxning kelajakdagi foydaga nisbati CRGT (Cortigent)|Kelajakdagi narxning foydaga nisbati Avenue Therapeutics (ATXI)|BCLI - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori CARA (Cara Therapeutics Inc)|CHRO - Prognoz qilingan narxning foydaga nisbati|ELYM: Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Intra-Cellular Therapies, Inc. ITCI|Longboard Pharma (LBPH) - Kelajakdagi narxning foydaga nisbati|Marinus - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati NKGen Biotech Inc|NRBO: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Neurotrope|Kelajakdagi narxning foydaga nisbati Trevena, Inc. TRVN|Vigil Neuroscience (VIGL) - Prognoz qilingan narx-foyda nisbati|WENA: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)